RESUMEN
Pulmonary arteriovenous malformations are common in patients with hereditary haemorrhagic telangiectasia and can be associated with significant hypoxia and intra-pulmonary shunt. We present a case of a young man with a known 57% calculated shunt requiring abdominal surgery and the multidisciplinary decisions required in the preoperative period to minimize post-operative complications.
RESUMEN
PURPOSE: The purpose of this study was to investigate whether preoperative dehydration and intraoperative hypotension were associated with postoperative acute kidney injury in patients managed surgically for kidney tumours. METHODS: A retrospective analysis of 184 patients who underwent nephrectomy at a single centre was performed, investigating associations between acute kidney injury after nephrectomy, and both intraoperative hypotension and preoperative hydration/volume status. Intraoperative hypotension was defined as mean arterial pressure < 60 mmHg for ≥ 5 min. Urine conductivity was evaluated as a surrogate measure of preoperative hydration (euhydrated < 15 mS/cm; mildly dehydrated 15-20 mS/cm; dehydrated > 20 mS/cm). Multivariable logistic regression was used to evaluate associations between exposures and the primary outcome, with adjustment made for potential confounders. RESULTS: Patients who were dehydrated and mildly dehydrated had an increased risk of acute kidney injury (adjusted odds ratio [aOR] 4.1, 95% CI 1.3-13.5; and aOR 2.4, 95% CI 1.1-5.3, respectively) compared with euhydrated patients (p = 0.009). Surgical approach appeared to modify this effect, where dehydrated patients undergoing laparoscopic surgery were most likely to develop acute kidney injury, compared with patients managed using an open approach. Intraoperative hypotension was not associated with acute kidney injury. CONCLUSION: Preoperative dehydration may be associated with postoperative acute kidney injury. Avoiding dehydration in the preoperative period may be advisable, and adherence to international evidence-based guidelines on preoperative fasting is recommended.
Asunto(s)
Lesión Renal Aguda/etiología , Carcinoma de Células Renales/cirugía , Deshidratación/complicaciones , Hipotensión/complicaciones , Neoplasias Renales/cirugía , Nefrectomía/efectos adversos , Centros Médicos Académicos , Lesión Renal Aguda/fisiopatología , Lesión Renal Aguda/terapia , Anciano , Carcinoma de Células Renales/patología , Carcinoma de Células Renales/fisiopatología , Estudios de Cohortes , Deshidratación/diagnóstico , Femenino , Tasa de Filtración Glomerular/fisiología , Humanos , Hipotensión/diagnóstico , Neoplasias Renales/patología , Neoplasias Renales/fisiopatología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Monitoreo Intraoperatorio/métodos , Análisis Multivariante , Nefrectomía/métodos , Oportunidad Relativa , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/terapia , Periodo Preoperatorio , Estudios Retrospectivos , Medición de RiesgoRESUMEN
Neoadjuvant therapy (NAT) for oesophageal cancer may reduce cardiopulmonary function, assessed by cardiopulmonary exercise testing (CPEX). Impaired cardiopulmonary function is associated with mortality following esophagectomy. We sought to assess the impact of NAT on cardiopulmonary function using CPEX and assessing the clinical relevance of any change in particular if changes were associated with post-operative morbidity. This was a prospective, cohort study of 40 patients in whom CPEX was performed before and after NAT. Thirty-eight patients underwent surgery and follow-up with perioperative outcomes measured. The primary variables derived from CPEX were the anaerobic threshold (AT) and peak oxygen uptake (VËO2peak). There were significant reductions in the AT (pre-NAT: 12.4⯱â¯3.0 vs. post-NAT 10.6⯱â¯2.0â¯mLâ¯kg-1.min-1; pâ¯=â¯0.001). This reduction was also evident for VËO2peak (pre-NAT: 16.6⯱â¯3.6 vs. post-NAT 14.9⯱â¯3.7â¯mLâ¯kg-1.min-1; pâ¯=â¯0.004). The relative reduction in VËO2peak was greater in chemotherapy patients who developed any peri-operative morbidity (pâ¯=â¯0.04). For patients who underwent chemoradiotherapy, there was a significantly greater relative reduction in AT (pâ¯=â¯0.03) for those who encountered a respiratory complication. Cardiopulmonary function significantly declined as a result of NAT prior to oesophagectomy. The reduction in AT and VËO2peak was similar in both the chemotherapy and chemoradiotherapy groups.